Ocular Surface Disease

Maybe it’s just me. I mean, maybe I’m the only one who continually tilts at the great big pharma/PBM/insurance windmill trying to get them to cover the cost of medication.

Here we are on the cusp of a new decade. There are all kinds of new things in literally every pipeline in eye care.

Positive study results and a study investigating shunt placement led glaucoma news in January.

Lunchtime reading: the point/counterpoint discussion of ocular surface issues in glaucoma care between Drs. Laura Periman and Doug Rhee. (I’m a little behind on some of my reading.)

Ocular surface disease is a common glaucoma comorbidity, but only a small percentage of respondents among the Canadian Glaucoma Society believe it is adequately managed, according to a study.

Eyes with meibomian gland dysfunction treated with vectored thermal pulsation experienced improved visible meibomian gland structure compared with eyes in a nontreatment control group.

Bruder, in association with leading ophthalmic surgeons and comanaging optometrists, announced the release of the Bruder Sx Pre-surgical Patient Prep Kit in a press release.

Smartphone screens produced the fewest visual disturbances to the ocular surface, while researchers observed highest disturbances after computer use, according to findings published in Optometry and Vision Science.

Red, irritated eyes and eyelids, fluctuating vision and ocular fatigue are common findings in patients with dry eye as well as those with glaucoma.

Glaucoma-related ocular surface disease is a significant and often underdiagnosed ocular comorbidity that can significantly affect quality of life.